drugset / Press release
Orphan drug designation for SOM0226
2014-01-17 · SOM Innovation Biotech SA · original sombiotech.com ↗
SOM Biotech announces Orphan Drug Designation in US for SOM0226, a compound for the treatment of Transthyretin Amyloidosis (ATTR). PRESS RELEASE
The release as fetched from its publisher. sombiotech.com ↗